BQ Blue’s special research section collates quality and in-depth equity and economy research reports from across India’s top brokerages. These reports offer BloombergQuint’s subscribers an opportunity to expand their understanding of companies, sectors and the economy.
HDFC Securities Report
Cardiac is the largest therapy (Rs 183 billion in size) in the Indian pharma market, accounting for approximately 13% share in it and growing at 10% compound annual growth rate.
We expect it to remain a dominant therapy for the next 10-15 years and gain 300-400 basis points share in the same period.
Taking into cognizance the importance of this therapy, we deep dive into the Indian cardiac market to identify the potential winners in this space.
Click on the attachment to read the full report:
DISCLAIMER
This report is authored by an external party. BloombergQuint does not vouch for the accuracy of its contents nor is responsible for them in any way. The contents of this section do not constitute investment advice. For that you must always consult an expert based on your individual needs. The views expressed in the report are that of the brokerage and do not represent the views of BloombergQuint.
Users have no license to copy, modify, or distribute the content without permission of the Original Owner.
As a Subscriber you get
Stories
RECOMMENDED FOR YOU
POPULAR